The effect of seven diseases on culling was measured in 7523 Holstein cows in New York State. The cows were from 14 herds and had calved between January 1, 1994 and December 31, 1994; all cows were followed until September 30, 1995. Survival analysis was performed using the Cox proportional hazards model to incorporate time-dependent covariates for diseases. Different intervals representing stages of lactation were considered for effects of the diseases. Five models were fitted to test how milk yield and conception status modified the effect of diseases on culling. Covariates in the models included parity, calving season, and time-dependent covariates measuring diseases, milk yield of the current lactation, and conception status. Data were stratified by herd. The seven diseases and lactational risks under consideration were milk fever (0.9%), retained placenta (9.5%), displaced abomasum (5.3%), ketosis (5.0%), metritis (4.2%), ovarian cysts (10.6%), and mastitis (14.5%). Older cows were at a much higher risk of being culled. Calving season had no effect on culling. Higher milk yield was protective against culling. Once a cow had conceived again, her risk of culling dropped sharply. In all models, mastitis was an important risk factor throughout lactation. Milk fever, retained placenta, displaced abomasum, ketosis, and ovarian cysts also significantly affected culling at different stages of lactation. Metritis had no effect on culling. The magnitude of the effects of the diseases decreased, but remained important, when milk yield and conception status were included as covariates. These results indicated that diseases have an important impact on the actual decision to cull and the timing of culling. Parity, milk yield, and conception status are also important factors in culling decisions.

An algorithm using only computer-based records to guide selective dry-cow therapy was evaluated at a New York State dairy farm via a randomized field trial. DairyComp 305 (Valley Ag Software, Tulare, CA) and Dairy Herd Improvement Association test-day data were used to identify cows as low risk (cows that might not benefit from dry-cow antibiotics) or high risk (cows that will likely benefit). Low-risk cows were those that had all of the following: somatic cell count (SCC) ≤200,000 cells/mL at last test, an average SCC ≤200,000 cells/mL over the last 3 tests, no signs of clinical mastitis at dry-off, and no more than 1 clinical mastitis event in the current lactation. Low-risk cows were randomly assigned to receive intramammary antibiotics and external teat sealant (ABXTS) or external teat sealant only (TS) at dry-off. Using pre-dry-off and postcalving quarter-level culture results, low-risk quarters were assessed for microbiological cure risk and new infection risk. Groups were also assessed for differences in first-test milk yield and linear scores, individual milk weights for the first 30 d, and culling and mastitis events before 30 d in milk. A total of 304 cows and 1,040 quarters in the ABXTS group and 307 cows and 1,058 quarters in the TS group were enrolled. Among cows to be dried, the proportion of cows that met low-risk criteria was 64% (n = 611/953). Of cultures eligible for bacteriological cure analysis (n = 171), 93% of ABXTS cured, whereas 88% of TS cured. Of the non-cures, 95% were contributed by the minor pathogens coagulase-negative staphylococci (n = 19/20). These organisms also accounted for 57.5% of new infections (n = 77/134). We found no statistical differences between treatment groups for new infection risk (TS = 7.3% quarters experiencing new infections; ABXTS = 5.5%), milk production (ABXTS = 40.5 kg; TS = 41.2 kg), linear scores (ABXTS = 2.5; TS = 2.7), culling events (ABXTS, n = 18; TS, n = 15), or clinical mastitis events (ABXTS, n = 9; TS, n = 5). Results suggest that the algorithm used decreased dry-cow antibiotic use by approximately 60% without adversely affecting production or health outcomes.

Widespread commercial application of sexed semen is expected within the next decade because of continued improvements in fertility of sexed semen and sorting capacity. The objective of this study was to explore the potential impact of widespread application of sexed semen on the structure of the dairy industry in the United States. Historically, female offspring from all heifers and cows were needed to produce enough dairy replacement heifers to replace culled cows. The use of sexed semen allows for a decoupling of breeding decisions necessary to obtain an adequate supply of dairy replacement heifers from those needed to achieve pregnancies needed to start new lactations. Application of sexed semen allows dairy producers to select among their herds' potential dams and produce dairy replacement heifers from only the genetically superior animals. The rate of genetic progress is expected to increase, but not more than 15% of the rate of gain accomplished through sire selection achieved through conventional (nonsexed) artificial insemination breeding. The supply of dairy replacement heifers is expected to grow to meet and temporarily exceed current demand, resulting in reduced prices for dairy replacement heifers. Consequently, herd turnover rates are expected to increase slightly, and herd expansions may accelerate. The rate of consolidation of dairy farms is expected to increase. Widespread application of sexed semen may temporarily increase the supply of milk, which would result in lower milk prices. The cost of milk production will be reduced as well. Many breeding options exist for the genetically poorer cows in the herd. The optimal breeding mix depends on the value of the various kinds of calves that could be produced. More crossbred calves for beef production may be produced; however, a market for these crossbred calves is not well established. Increased specialization is expected with more dairy producers deciding not to raise their own heifers but to purchase replacements. Other dairy farms might specialize in producing genetically superior dairy replacement heifers for sale. Depending on the value of calves not raised for replacements, artificial insemination organizations might market beef conventional semen or beef male sexed semen to dairy farms. The use of sexed semen should lower the cost of progeny-testing programs and embryo transfer and enhance the value of genetic markers. Eventually, the economic benefits from the use of sexed semen will be passed on to consumers.

Logistic regression was used to examine the association between milk yield and disease. We studied 8070 cows of second or higher parity from 25 New York State Holstein herds, calving between June 1990 and November 1993. Previous 305-d mature equivalent milk yield was used because most of the disorders studied occurred too early in lactation for current milk yield to be considered. Seven disorders were studied: retained placenta, metritis, ovarian cyst, milk fever, ketosis, abomasal displacement, and mastitis. A separate model was used for each disorder. Each model included, in additional to milk yield, parity, calving season, and heard. Results showed that higher milk yield was not a risk factor for any disease except mastitis. However, the association between higher previous milk yield and mastitis does not necessarily imply causation.